Hi Vivien,
There was a recent paper published in Nature Communications discussing a second generation vaccine on Leishmaniasis using CRISPR to knockout the gene centrin (this eliminates antibody resistance) in L. major (a less risky live-attenuated model than L. donovani)
Here is the link to the paper https://www.nature.com/articles/s41467-020-17154-z